***Background.*** Antimicrobial stewardship can minimize adverse events from antibiotics, development of resistance, and costs. Two potential stewardship targets are in initiation and streamlining of therapy.

***Methods.*** We examined indicators of quality in initiating and streamlining antibiotic therapy between two Veterans Affairs (VA) hospitals with different stewardship programs: VA Greater Los Angeles (GLA), which has a dedicated full-time infectious diseases (ID) pharmacist who reviews all broad-spectrum parenteral antibiotic usage, and the Denver VA (DEN), which has a more decentralized model where individual ward pharmacists are responsible for stewardship. We reviewed a sample of 300 cases of inpatient parenteral antibiotic use (200 at GLA from October 2011-October 2012 and 100 at DEN from July 2010-June 2011).

***Results.*** For antibiotic indication, GLA cases were more likely to have an indication for antibiotic therapy documented \[199/200 (99%) vs 95/100 (95%), p = 0.017\] and appropriate empirical therapy prescribed \[194/200 (97%) vs 87/100 (87%), p = 0.002\] but were less likely to have appropriate cultures collected \[121/186 (65%) vs 82/100 (82%), p = 0.002\]. For antibiotic streamlining, GLA cases were more likely to have therapy modified within 24 hours of lab data being available \[133/152 (87%) vs 37/51 (73%), p = 0.016\], to be converted to oral medication appropriately \[100/123 (81%) vs 41/67 (61%), p = 0.003\], and to have antibiotics discontinued when bacterial infection was determined to not be present \[39/50 (78%) vs 11/33 (33%), p \< 0.0001\]. The presence of any streamlining activity was higher at GLA regardless of whether ID consultation was obtained \[174/191 (91%) vs 47/95 (49%) overall and 128/143 (90%) vs 36/70 (51%) without ID consult, p \< 0.0001 for both\].

***Conclusion.*** Our findings strongly support the presence of a full-time ID pharmacist in antimicrobial stewardship, particularly in influencing streamlining of therapy, but opportunities for improvement in both initiation of and streamlining of therapy still exist even when a full-time ID pharmacist is present.
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